['asthma']
['chf 5259 plus foster 100/6 µg', 'foster 100/6 µg']

        Inclusion Criteria:

          -  Male or female patients aged >=18 years

          -  Uncontrolled asthma on medium doses of ICS+LABA with ACQ >=1.5

          -  Pre-bronchodilator FEV1 ≥40% and <80% of their predicted normal value

        Exclusion Criteria:

          -  Pregnant or lactating women

          -  Diagnosis of COPD

          -  Patients treated for asthma exacerbations in the 4 weeks prior to study entry

          -  Patients who are in therapy for gastroesophageal reflux disease

          -  Patients who have a clinically significant cardiovascular condition
      